Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m. Production & Manufacturing > Manufacturing > News
Tiziana launches phase IIa trial of milciclib in HCC patients Tiziana Life Sciences has started enrolling of patients in its phase IIa clinical trial with cyclin-dependent kinases (CDKs) inhibitor milciclib in patients with refractory hepatocellular carcinoma (HCC).
Contract Research & Services > Clinical Trials > News Vertex reports positive data from cystic fibrosis trials Vertex Pharmaceuticals has reported positive data from Phase 1 and Phase 2 trials of three different triple combination regimens in cystic fibrosis (CF) patients who have one F508del mutation and one minimal function mutation (F508del/Min).
Contract Research & Services > Clinical Trials > News Horizon to acquire GE's gene tech business Dharmacon By PBR Staff Writer
Gene editing company Horizon Discovery Group (HDG) has agreed to acquire General Electric’s (GE) gene tech business Dharmacon for $85m.
Production & Manufacturing > Manufacturing > News
Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab By PKBR Staff Writer
Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m.
Production & Manufacturing > Manufacturing > News GlobalData says acute myeloid leukemia market will cross $1.5bn by 2026 The acute myeloid leukemia (AML) market in the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will grow more than three times from $406m in 2016 to more than $1.5bn by 2026, reflecting a compound annual growth rate of 14%, as per research and consulting firm GlobalData.
Drug Research > Drug Delivery > News Prana partners with Takeda in Parkinson’s gastrointestinal neuropathology Prana Biotechnology has entered into a research collaboration with Takeda Pharmaceuticals International to study the potential of its investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.
Contract Research & Services > Contract Research > News

Latest News and Insight by Sector

Production & Manufacturing

Horizon to acquire GE's gene tech business Dharmacon
By PBR Staff Writer
Gene editing company Horizon Discovery Group (HDG) has agreed to acquire General Electric’s (GE) gene tech business Dharmacon for $85m.
Production & Manufacturing > Manufacturing > News
Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab
By PKBR Staff Writer
Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m.
Production & Manufacturing > Manufacturing > News

Drug Research

GlobalData says acute myeloid leukemia market will cross $1.5bn by 2026
The acute myeloid leukemia (AML) market in the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will grow more than three times from $406m in 2016 to more than $1.5bn by 2026, reflecting a compound annual growth rate of 14%, as per research and consulting firm GlobalData.
Drug Research > Drug Delivery > News
Sarepta, BioMarin settle patent litigation over DMD exon-skipping drugs
By PBR Staff Writer
Sarepta Therapeutics and BioMarin Pharmaceutical have settled a global patent litigation relating to the use of the former’s Exondys 51 and all future exon-skipping products for the treatment of Duchenne muscular dystrophy (DMD).
Drug Research > Drug Delivery > News

Inward Investment

New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

Packaging

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals
MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News

Contract Research & Services

Tiziana launches phase IIa trial of milciclib in HCC patients
Tiziana Life Sciences has started enrolling of patients in its phase IIa clinical trial with cyclin-dependent kinases (CDKs) inhibitor milciclib in patients with refractory hepatocellular carcinoma (HCC).
Contract Research & Services > Clinical Trials > News
Vertex reports positive data from cystic fibrosis trials
Vertex Pharmaceuticals has reported positive data from Phase 1 and Phase 2 trials of three different triple combination regimens in cystic fibrosis (CF) patients who have one F508del mutation and one minimal function mutation (F508del/Min).
Contract Research & Services > Clinical Trials > News

Automation

Broad Institute of MIT and Harvard joins discussions to create global CRISPR-Cas9 licensing pool
The Broad Institute of MIT and Harvard has joined discussions to form a non-exclusive CRISPR-Cas9 joint licensing pool coordinated by MPEG LA, an organization that operates patent pool licensing programs in various institutions and countries.
Automation > IT & Software > News
Servier, Transgene to apply viral vectorization technology to engineering of allogenic CAR-T
Servier and Transgene have signed a research agreement on the application of viral vectorization technology for the production of allogenic CAR-T cell therapies.
Automation > IT & Software > News

Regulatory Affairs

FDA approves Gilead’s Vosevi to re-treat HCV infection in adults
By PBR Staff Writer
Gilead Sciences has secured approval from the US Food and Drug Administration (FDA) for its Vosevi to re-treat adults with chronic hepatitis C virus (HCV) infection.
Regulatory Affairs > News
FDA rejects Amgen’s BLA for osteoporosis treatment Evenity
By PBR Staff Writer
The US Food and Drug Administration (FDA) has rejected Amgen and UCB’s biologics license application (BLA) for Evenity (romosozumab) to treat postmenopausal women with osteoporosis
Regulatory Affairs > News



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery